BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16285894)

  • 81. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.
    O'Neill D; Bhardwaj N
    Methods Mol Med; 2005; 109():1-18. PubMed ID: 15585909
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Case report on intra-tumor injection therapy of dendritic cells in advanced gastric cancer].
    Kanazawa M; Yoshihara K; Abe H; Iwadate M; Watanabe K; Suzuki S; Endoh Y; Ohki S; Takita K; Sekikawa K; Takenoshita S; Takagi T; Irisawa A; Sato Y; Ogata T; Ohto H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1773-6. PubMed ID: 15553711
    [TBL] [Abstract][Full Text] [Related]  

  • 83. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia.
    Dietz AB; Litzow MR; Gastineau DA; Vuk-Pavlović S
    Croat Med J; 2001 Aug; 42(4):428-35. PubMed ID: 11471194
    [TBL] [Abstract][Full Text] [Related]  

  • 85. DC therapy for metastatic melanoma.
    Ingram SB; O'Rourke MG
    Cytotherapy; 2004; 6(2):148-53. PubMed ID: 15203991
    [No Abstract]   [Full Text] [Related]  

  • 86. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dendritic cell therapy in advanced gastric cancer: a promising new hope?
    Tewari M; Sahai S; Mishra RR; Shukla SK; Shukla HS
    Surg Oncol; 2012 Sep; 21(3):164-71. PubMed ID: 22521560
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dendritic cell-based vaccines: clinical applications in breast cancer.
    Gelao L; Criscitiello C; Esposito A; De Laurentiis M; Fumagalli L; Locatelli MA; Minchella I; Santangelo M; De Placido S; Goldhirsch A; Curigliano G
    Immunotherapy; 2014; 6(3):349-60. PubMed ID: 24762078
    [TBL] [Abstract][Full Text] [Related]  

  • 89. mRNA-based dendritic cell vaccines.
    Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
    Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dendritic cell preparation for immunotherapeutic interventions.
    Simon T; Fonteneau JF; Grégoire M
    Immunotherapy; 2009 Mar; 1(2):289-302. PubMed ID: 20635946
    [TBL] [Abstract][Full Text] [Related]  

  • 91. DCs as targets for vaccine design.
    Belz G; Smith C; Bharadwaj M; Rice A; Jackson D
    Cytotherapy; 2004; 6(2):88-98. PubMed ID: 15203984
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dendritic cell based tumor vaccines.
    Nouri-Shirazi M; Banchereau J; Fay J; Palucka K
    Immunol Lett; 2000 Sep; 74(1):5-10. PubMed ID: 10996622
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Building on dendritic cell subsets to improve cancer vaccines.
    Palucka K; Ueno H; Zurawski G; Fay J; Banchereau J
    Curr Opin Immunol; 2010 Apr; 22(2):258-63. PubMed ID: 20226644
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Harnessing dendritic cells for immunotherapy.
    Delamarre L; Mellman I
    Semin Immunol; 2011 Feb; 23(1):2-11. PubMed ID: 21377379
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2010 Apr; 42(2):189-92. PubMed ID: 20122870
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ex vivo enhancement of antigen-presenting function of dendritic cells and its application for DC-based immunotherapy.
    Nieda M; Tomiyama M; Egawa K
    Hum Cell; 2003 Dec; 16(4):199-204. PubMed ID: 15147040
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunobiology of dendritic cells.
    Banchereau J; Briere F; Caux C; Davoust J; Lebecque S; Liu YJ; Pulendran B; Palucka K
    Annu Rev Immunol; 2000; 18():767-811. PubMed ID: 10837075
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Antitumor cellular immunotherapy: the breakthrough of dendritic cells].
    Angevin E; André F; Zitvogel L
    Bull Cancer; 2000 Jan; 87(1):107-15. PubMed ID: 10673639
    [No Abstract]   [Full Text] [Related]  

  • 99. The ABCs of artificial antigen presentation.
    Kim JV; Latouche JB; Rivière I; Sadelain M
    Nat Biotechnol; 2004 Apr; 22(4):403-10. PubMed ID: 15060556
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Immunotherapy for colorectal cancer.
    Midgley RS; Kerr DJ
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.